Your browser doesn't support javascript.
loading
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis.
Im, Gene Y; Goel, Aparna; Asrani, Sumeet; Singal, Ashwani K; Wall, Anji; Sherman, Courtney B.
Afiliación
  • Im GY; Icahn School of Medicine at Mount Sinai, Division of Liver Diseases, Recanati/Miller Transplantation Institute, New York, New York, USA.
  • Goel A; Division of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, California, USA.
  • Asrani S; Baylor University Medical Center, Baylor Scott and White, Dallas, Texas, USA.
  • Singal AK; University of Louisville School of Medicine, Louisville, Kentucky, USA.
  • Wall A; Baylor University Medical Center, Baylor Scott and White, Dallas, Texas, USA.
  • Sherman CB; Division of Gastroenterology and Hepatology, University of California, San Francisco, California, USA.
Liver Transpl ; 2023 Nov 28.
Article en En | MEDLINE | ID: mdl-38009866
ABSTRACT
Liver transplantation (LT) for alcohol-associated hepatitis (AH) remains controversial due to concerns about candidate selection subjectivity, post-LT alcohol relapse, and the potential exacerbation of LT disparities. Our aim was to design, perform, and examine the results of a simulated selection of candidates for LT for AH. Medical histories, psychosocial profiles and scores, and outcomes of 4 simulation candidates were presented and discussed at 2 multidisciplinary societal conferences with real-time polling of participant responses. Candidate psychosocial profiles represented a wide spectrum of alcohol relapse risk. The predictive accuracy of four psychosocial scores, Dallas consensus criteria, sustained alcohol use post-LT, Stanford Integrated Psychosocial Assessment for Transplant, and QuickTrans, were assessed. Overall, 68 providers, mostly academic transplant hepatologists, participated in the simulation. Using a democratic process of selection, a significant majority from both simulations voted to accept the lowest psychosocial risk candidate for LT (72% and 85%) and decline the highest risk candidate (78% and 90%). For the 2 borderline-risk candidates, a narrower majority voted to decline (56% and 65%; 64% and 82%). Two out of 4 patients had post-LT relapse. Predictive accuracies of Dallas, Stanford Integrated Psychosocial Assessment for Transplant, and Quicktrans scores were 50%, while sustained alcohol use post-LT was 25%. The majority of voting outcomes were concordant with post-LT relapse in 3 out of 4 patients. When defining "success" in LT for AH, providers prioritized allograft health and quality of life rather than strict abstinence. In this simulation of LT for AH using a democratic process of selection, we demonstrate its potential as a learning model to evaluate the accuracy of psychosocial scores in predicting post-LT relapse and the concordance of majority voting with post-LT outcomes. Provider definitions of "success" in LT for AH have shifted toward patient-centered outcomes.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Liver Transpl Asunto de la revista: GASTROENTEROLOGIA / TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Liver Transpl Asunto de la revista: GASTROENTEROLOGIA / TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos